Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines

British Journal of Cancer

Volumn 77, Issue 10, 1998, Pages 1562-1567

  Burger, H ^a   Nooter, K ^a,b   Boersma, A W M ^a   Kortland, C J ^a   Stoter, G ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Bcl 2 Bax protein family; Cisplatin; p53; Testicular germ cell tumour cell line

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; GERM CELL TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE;

EID: 0031982327     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.257     Document Type: Article

References (30)

1. Boersma AWM, Nooter K, Burger H, Kortland CJ and Stoter G (1997) Bax upregulation is an early event in cisplatin-induced apoptosis in human testicular germ cell tumour cell line NT2, as quantitated by flow cytometry. Cytometry 27: 275-282
2. Carimchael J, De Graff WG, Gadzar AF, Minna JD and Mitchell JB (1987) Evaluation of a tetrazolium-based semi-automated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-947
3. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper MI, and Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways, Nature 362: 849-852
4. Cresta CM, Masters JRW and Hickman JA (1996) Hypersensitivity of human testicular tumours to etoposide-induced apoptosis is associated with functional p53 and a high Bax: Bcl-2 ratio. Cancer Res 56: 1834-1841
5. Damjanov I, Horvat B and Gibas Z (1993) Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumour-derived cell line, NCCIT. Lab Invest 68: 220-232
6. Dive C and Hickman JA (1991) Drug larget interactions: only the first step in the commitment to a programmed cell death? Br J Cancer 64: 192-196
7. Einhorn LH (1990) Treatment of testicular cancer: a new and improved model. J Clin Oncol 8: 1777-1781
8. El-Deiry WS, Tokino T, Veleulescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW and Vogelstein B (1993) WAF1 a potent mediator of p53 tumour suppression. Cell 75: 817-825
9. Fan S, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace Jr AJ, Magrath I, Kohn KW and O'Connor PM (1994) p53 Gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54: 5824-5830
10. Fisher DE (1994) Apoptosis in cancer therapy: crossing the threshold. Cell 78: 534-542
11. Harris CC (1996) Structure and function of the p53 tumour suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88: 1442-1452
12. Hill BT, Seanlon KJ, Hansson J, Harstrick A, Pera M, Fichtinger-Sehepman AMJ and Shellard SA (1994) Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients, Eur J Cancer 30A: 832-837
13. Huddart RA, Titley J, Robertson D, Williams GT, Horwich A and Cooper CS (1995) Programmed cell death in response to chematherapeutic agents in human germ cell tumour lines. Eur J Cancer 31A: 739-746
14. Ishikawa T, Wright CD and Ishizuka H (1994) GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J Biol Chem 269: 29085-29093
15. Kaufmann SC, Desnoyers S, Ottaviano Y, Davidson NE and Poirier GG (1993) Specific proteolytic cleavage of polyl(ADP-ribose polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976-3985
16. Kerr JFR, Winterford CM and Harmon BV (1994) Apoptosis: its significance in cancer and cancer chemotherapy. Cancer 73: 2013-2026
17. Korsmeyer SJ (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80: 876-886
18. Lotem J and Sachs L (1993) Regulation by Bcl-2, c-myc, and p53 of susceptibility to induced apoptosis by heat-schock and cancer chemotherapy compounds in differentiation competent and defective mycloid leukemia Cell Growth Diff 4: 41-47
19. Lowe SW, Ruley HE, Jacks T and Housman DE (1993) p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967
20. Masters JRW, Osborne EJ, Walker MC and Parris CN (1993) Hypersensitivity of human testis tumour cell lines to chemotherapeutic drugs. Int J Cancer 53: 340-346
21. Miller SA, Dykes DD and Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215
22. Miyashita T, Krajewski S, Krajewski M, Wang HG, Lin HK, Liebermann DA, Hofmann B and Reed JC (1994) Tumour suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vitro. Oncogene 9: 1799-1805
23. Oltvai ZN and Korsmeyer SJ (1994) Checkpoints of duelling dimers foil death wishes. Cell 79: 189-192
24. Peng HQ, Hogg D, Malkin D, Bailey D, Gallie BL, Bulhul M, Jewett M, Buchanan J and Gross PE (1993) Mutations of the p53 gene do not occur in testis cancer. Cancer Res 53: 3574-3578
25. Reed JC, Miyashita T, Takayama S, Wang H-G. Sato T, Krajewski S, Aimé-Sempé C, Bodrug S, Kitada S and Hanada M (1996) Bcl-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance therapy. J Cell Biochem 60: 23-32
26. Sark MWJ, Timmer-Bosscha H, Mcijer C, Uges DRA, Sluiter WJ, Peters WHM, Mulder NH and de Vries EGE (1995) Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines. Br J Cancer 71: 684-690
27. Wang N, Perkins KI, Bronson DI and Fraley EE (1981) Cytogenetic evidence for premeiotic transformation of human testicular cancers. Cancer Res 41: 2135-2140
28. Wang XW, Vermeulen W, Coursen JD, Gibson M, Lupold SE, Forrester K, Xu G, Elmore L, Yeh H, Hoeijmakers JHJ and Harris CC (1996) The XPB and XPD helicases are components of the p53-mediated apoptosis pathway Genes Dev 10: 1219-1232
29. Zakut-Houri R, Bienz-Tadmor B, Givol D and Ohren M (1985) Human p53 cellular tumour antigen: cDNA sequence and expression in COS cells. EMBO J 4: 1251-1255
30. Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM and Fornace AJ (1994) Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9: 3743-3751